Literature DB >> 16783474

A critical evaluation of Tm(FTIR) measurements of high-concentration IgG1 antibody formulations as a formulation development tool.

Susanne Matheus1, Hanns-Christian Mahler, Wolfgang Friess.   

Abstract

PURPOSE: Fourier-transform infrared (FTIR) spectroscopy was applied for the determination of protein melting temperature (Tm(FTIR)) and to assess the stability predictability of a 100-mg/mL liquid IgG1 antibody formulation.
METHODS: Tm(FTIR) values of various formulations (different pH, buffers, excipients) were compared to the results of a stability study under accelerated conditions (40 degrees C/75% relative humidity), using size-exclusion high-performance liquid chromatography (SE-HPLC) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for the detection of soluble aggregates and covalent modifications.
RESULTS: The highest Tm(FTIR) was achieved at pH 5.5, and, similarly, SE-HPLC and SDS-PAGE results suggested a pH optimum between 5.5 and 6.0. Transition temperatures were comparable for all tested buffers. However, the decrease in the monomer fraction upon thermal storage was the lowest for citrate buffers. Whereas sugars and polyols resulted in an increase in Tm(FTIR) and enhanced monomer fraction after storage, amino acids showed a destabilization according to SE-HPLC analysis, albeit no change or even an increase in the melting temperature was observed.
CONCLUSIONS: All examples gave evidence that Tm(FTIR) values did not necessarily correspond to the storage stability at 40 degrees C analyzed by means of SE-HPLC and SDS-PAGE. Tm values, e.g., determined by FTIR, should only be employed as supportive information to the results from both real-time and accelerated stability studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783474     DOI: 10.1007/s11095-006-0283-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  Effect of polyols on the conformational stability and biological activity of a model protein lysozyme.

Authors:  Somnath Singh; Jagdish Singh
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

Review 2.  Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals.

Authors:  David B Volkin; Gautam Sanyal; Carl J Burke; C Russell Middaugh
Journal:  Pharm Biotechnol       Date:  2002

3.  Thermal stability: a means to assure tertiary structure in therapeutic proteins.

Authors:  Mike Cauchy; Sophie D'Aoust; Brian Dawson; Harold Rode; Mary Alice Hefford
Journal:  Biologicals       Date:  2002-09       Impact factor: 1.856

Review 4.  New technologies in therapeutic antibody development.

Authors:  O H Brekke; G Å Løset
Journal:  Curr Opin Pharmacol       Date:  2003-10       Impact factor: 5.547

Review 5.  Understanding and increasing protein stability.

Authors:  C O Fágáin
Journal:  Biochim Biophys Acta       Date:  1995-09-27

Review 6.  Protein--solvent interactions in pharmaceutical formulations.

Authors:  T Arakawa; Y Kita; J F Carpenter
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 7.  IgG subclasses--a review.

Authors:  P H Schur
Journal:  Ann Allergy       Date:  1987-02

8.  Stabilization of protein structure by sugars.

Authors:  T Arakawa; S N Timasheff
Journal:  Biochemistry       Date:  1982-12-07       Impact factor: 3.162

9.  Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding.

Authors:  S D Allison; B Chang; T W Randolph; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1999-05-15       Impact factor: 4.013

10.  Aggregation of recombinant human interferon gamma: kinetics and structural transitions.

Authors:  B S Kendrick; J L Cleland; X Lam; T Nguyen; T W Randolph; M C Manning; J F Carpenter
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

View more
  2 in total

1.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

2.  Thermal unfolding curves of high concentration bovine IgG measured by FTIR spectroscopy.

Authors:  V Sathya Devi; Denis R Coleman; Jeremy Truntzer
Journal:  Protein J       Date:  2011-08       Impact factor: 2.371

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.